Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Matrix metalloproteinases and atherosclerosis.

Noboru Watanabe1, Uichi Ikeda

  • 1Shinshu University School of Medicine, Matsumoto, 390-8621, Japan. nwata-sin@umin.ac.jp

Current Atherosclerosis Reports
|March 17, 2004
PubMed
Summary

Matrix metalloproteinases (MMPs) degrade extracellular matrix in atherosclerosis, contributing to cardiovascular disease. Targeting MMPs and tissue inhibitors of metalloproteinases (TIMPs) may prevent atherosclerotic lesion progression and plaque rupture.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Molecular conformation of dimethyl oxalate studied by electron momentum spectroscopy.

Physical chemistry chemical physics : PCCP·2026
Same author

Effect of Tofogliflozin on Urinary Albumin-to-Creatinine Ratio vs. Metformin in Diabetic Kidney Disease: Rationale and Study Protocol of the TRUTH-DKD Trial.

Diabetes therapy : research, treatment and education of diabetes and related disorders·2025
Same author

Correction: Importance of Donor-Derived and Recipient-Derived Selectins in Cardiac Allograft Rejection.

Journal of the American Society of Nephrology : JASN·2025
Same author

Theoretical atomic momentum spectroscopy of diatomic, triatomic and polyatomic molecules.

Physical chemistry chemical physics : PCCP·2025
Same author

Impact of Low Bone Mineral Content Index on Cardiovascular Outcomes in Patients With Coronary Artery Disease Undergoing Percutaneous Coronary Intervention.

Angiology·2024
Same author

Real-world Practical Experience of Angiotensin Receptor-neprilysin Inhibitor in Older Japanese Patients with Chronic Heart Failure.

JMA journal·2023

Area of Science:

  • Cardiovascular Biology
  • Molecular Medicine
  • Biochemistry

Background:

  • Atherosclerosis, a primary cause of coronary heart disease, involves extracellular matrix degradation.
  • Matrix metalloproteinases (MMPs) are implicated in vascular remodeling and weakening of the vascular wall.
  • Enhanced MMP expression in atherosclerotic lesions highlights their pathogenic role.

Purpose of the Study:

  • To elucidate the role of MMPs and their inhibitors (TIMPs) in atherosclerosis.
  • To investigate the impact of MMPs on cardiovascular remodeling and disease progression.
  • To explore the therapeutic potential of targeting MMPs in cardiovascular disease.

Main Methods:

  • Analysis of MMP and TIMP expression in animal models and human clinical samples.

Related Experiment Videos

  • Investigation of regulatory mechanisms including transcription, enzyme processing, and inflammatory cytokine signaling.
  • Examination of genetic polymorphisms in MMP gene promoters.

    • Main Results:

    • MMPs contribute to atherosclerotic lesion development and vascular wall weakening.
    • The balance between MMPs and TIMPs is critical for stenotic and aneurysmal changes.
    • MMP gene polymorphisms influence individual susceptibility to coronary heart disease.

    Conclusions:

    • MMPs are key mediators in the development and progression of atherosclerosis.
    • Therapeutic strategies targeting MMPs show promise for preventing atherosclerotic complications.
    • Understanding MMP-TIMP interactions is crucial for managing cardiovascular disease.